CSF2 and colorectal cancer: The concentrations of IFN-γ and GM-CSF are shown in Figure 2B, the results suggest the impairment of N1 neutrophil-mediated anti-tumor function in patients with stage II and IIIB-C colorectal cancer and recovery in stage IV colorectal cancer.